Abstract:Metastasis is the cause of most triple-negative breast cancer deaths, yet anti-metastatic therapeutics remain limited. To develop new therapeutics to prevent metastasis, pathophysiologically relevant assays that recapitulate tumor microenvironment is essential for disease modeling and drug discovery. Here, we have developed a microfluidic metastasis-on-chip assay of the early stages of cancer metastasis integrated with the triple-negative breast cancer cell line (MDA-MB-231), stromal fibroblasts and a perfused microvessel. High-content imaging with automated quantification methods was optimized to assess the tumor cell invasion and intravasation within the model. Cell invasion and intravasation were enhanced when fibroblasts co-cultured with a breast cancer cell line (MDA-MB-231). However, the non-invasive breast cancer cell line, MCF7, remained non-invasive in our model, even in the presence of fibroblasts. High-content screening of a targeted anti-cancer therapy drug library was conducted to evaluate the drug response sensitivity of the optimized model. Through this screening, we identified 30 compounds that reduced the tumor intravasation by 60% compared to controls. Multi-parametric phenotypic analysis was applied by combining the data from the metastasis-on-chip, cell proliferation and 2D cell migration screens, revealing that the drug library was clustered into eight distinct groups with similar drug responses. Notably, MEK inhibitors were enriched in cluster cell invasion and intravasation. In contrast, drugs with molecular targets: ABL, KIT, PDGF, SRC, and VEGFR were enriched in the drug clusters showing a strong effect on tumor cell intravasation with less impact on cell invasion or cell proliferation, of which, Imatinib, a multi-kinase inhibitor targeting BCR-ABL/PDGFR/KIT. Further experimental analysis showed that Imatinib enhanced endothelial barrier stability as measured by trans-endothelial electrical resistance and significantly reduced the trans-endothelial invasion activity of tumor cells. Our findings demonstrate the potential of our metastasis-on-chip assay as a powerful tool for studying cancer metastasis biology, drug discovery aims, and assessing drug responses, offering prospects for personalized anti-metastatic therapies for triple-negative breast cancer patients.

A Cost-Effective Microdevice Bridges Microfluidic and Conventional in Vitro Scratch/Wound-Healing Assay for Personalized Therapy Validation

Recent Advances in Microfluidic Technology and Applications for Anti-Cancer Drug Screening

An on-chip wound healing assay fabricated by xurography for evaluation of dermal fibroblast cell migration and wound closure

Microfluidic Wound-Healing Assay for Comparative Study on Fluid Dynamic, Chemical and Mechanical Wounding on Microglia BV2 Migration

A PDMS Device Coupled with Culture Dish for in Vitro Cell Migration Assay

Self-Sterilizing and Regeneratable Microchip for the Precise Capture and Recovery of Viable Circulating Tumor Cells from Patients with Cancer.

Wound healing assay on a gravity-driven unidirectional perfusion microfluidic device

High-throughput Cell Migration Assay under Combinatorial Chemical Environments by a Novel 24-Well-plate Based Device

From Chips-in-Lab to Point-of-Care Live Cell Device: Development of a Microfluidic Device for On-Site Cell Culture and High-Throughput Drug Screening

A Novel Micro-Groove Impedance Sensor for 3D Cell Viability Monitoring and High-Throughput Drug Screening

A microfluidic wound-healing assay for quantifying endothelial cell migration

A microphysiological assay for studying T-cell chemotaxis, trafficking and tumor killing

Optimized Scratch Assay for In Vitro Testing of Cell Migration with an Automated Optical Camera

[A Simple Medical Research Microdevice for Analyzing Three-dimensional Migration of Tumor Cells in Vitro]

Microfluidic Device Featuring Micro-Constrained Channels for Multi-Parametric Assessment of Cellular Biomechanics and High-Precision Mechanical Phenotyping of Gastric Cells

A microfluidics-based wound-healing assay for studying the effects of shear stresses, wound widths, and chemicals on the wound-healing process

A passive pump-assisted microfluidic assay for quantifying endothelial wound healing in response to fluid shear stress

Microfluidic Analysis for Separating and Measuring the Deformability of Cancer Cell Subpopulations

On-chip cell migration assay using microfluidic channels

A Parallel and Quantitative Cell Migration Assay Using a Novel Multi-Well-based Device

Development of a cancer metastasis-on-chip assay for high throughput drug screening